Post-translational modifications of autoantigens are hypothesized to affect their immunogenicity. We here report that nitration of tyrosine 40 in Myelin Oligodendrocyte Glycoprotein (MOG) abrogates its encephalitogenicity both at protein and peptide levels in the experimental autoimmune encephalomyelitis (EAE) model in H2 b C57BL/6 mice. indicate that the lack of T cell reactivity towards nitrated MOG can be attributed to the inability of murine H2-IA b to efficiently present the altered peptide ligand of MOG because the nitrated tyrosine 40 cannot be accommodated in the p1 anchor pocket.
Introduction

Post-translational modifications and autoimmunity
The involvement and the importance of post-translational modifications (PTMs) in the development of autoimmune conditions are well-established, as extensively discussed elsewhere [1] [2] [3] . The major concepts connecting PTMs to autoimmunity are: 1) lack of central tolerance to MHC-restricted altered peptide ligands (APLs) and cross-reactivity; 2) presentation of novel cryptic epitopes under the auspices of altered processing events; and 3) recognition of modified antigens by antibodies, complement factors, pattern recognition or scavenger receptors [1] [2] [3] . Increased levels of PTMs are often associated with proinflammatory immune activation and cellular stress. Under these conditions the activity of many enzymes catalyzing chemical modifications or levels of oxidative mediators are elevated.
However, a decisive distinction should be made between the roles of modified antigens as opposed to regulation of cellular processes by production of reactive oxygen or nitrogen species (ROS/RNS). For instance, it has been demonstrated that the production of ROS by inflammatory cells may regulate autoimmune responses [4, 5] .
Production of reactive nitrogen species and protein nitration
Protein tyrosine nitration is a covalent post-translational modification of tyrosine residues mediated by reactive nitrogen species (RNS) [6] . A major source of RNS is the simultaneous production of nitric oxide and superoxide, forming peroxynitrite, which is especially associated with inflammatory phagocytes via inducible nitric oxide synthase (iNOS) and NADPH oxidase [6] . Furthermore, there is considerable production of RNS in mitochondria with variable effects on target proteins [7] . Protein nitration associated with inflammation has been implicated as a marker of RNS production, as well as a factor potentially driving the development of various diseases [8] .
Evidence of nitrative stress in the pathology of Multiple Sclerosis
Multiple Sclerosis (MS) is a demyelinating disease with recurrent autoimmune inflammation directed towards myelin components in the central nervous system (CNS) [9, 10] . There are several lines of evidence suggesting a role for RNS and nitration in MS pathology. For instance, mitochondria have long been suggested to be important for the progression of MS [11] . Histological staining demonstrates that protein nitration is abundant in MS lesions [12] . Nitration being strongly associated with mononuclear phagocytes and active lesions, but not to chronic lesions implies an involvement of nitration in active or early MS [13] . Furthermore, oligodendrocytes can be triggered by LPS to produce RNS via neuronal NOS [14] , and peroxynitrite has been proposed as a mediator of oligodendrocyte death [12] . ROS/RNS are thus strongly implicated in the neurodegenerative aspects of MS [15] . In relapsing MS patients there is evidence of elevated iNOS, RNS, nitration and S-nitrosylation in both cerebrospinal fluid [16] and white matter [17] . iNOS is also essential for production of RNS and protein nitration by microglia [18] . Taken together, there is thus a consensus that protein nitration is a hallmark of CNS inflammation, though its role and underlying mechanism remain to be fully elucidated.
iNOS and protein nitration in the EAE model
As studies of pathological processes in patients or post-mortem material are limited, the role of iNOS has been addressed using the animal model of MS, Experimental autoimmune encephalomyelitis (EAE). Several independent studies suggest a protective role for iNOS in EAE, as gene deletion models display more severe EAE phenotypes and higher incidence [19] [20] [21] . However, other studies contradict these results as inhibition of iNOS has been reported to be protective in active EAE models [22, 23] . The neurodegenerative aspect of EAE appears to be aggravated by protein nitration, and possibly primes for disease [24] , with potential exacerbation by iron deposits [25] . Furthermore, a recent study included clear evidence of nitrative damage during EAE, as well as treatment benefits using scavengers [26] . Lastly, even the virally induced Theiler's murine encephalomyelitis model provides evidence for involvement of iNOS [27] .
In light of apparent controversy and despite extensive research, the distinct roles and interplay of iNOS in inflammatory cells [28] , RNS-mediated neurodegeneration and protein nitration remain incompletely understood.
Presentation of nitrated antigen
The immunological consequences of protein nitration remain controversial [29] . Whether nitration promotes antigen presentation and immunogenicity, or instead denies it and entails escape from recognition is a matter of scientific debate. Among others, there are studies demonstrating protein nitration to enhance antigen presentation [30] , to promote autoimmunity via lack of central tolerance [31] or alternatively being selectively presented [32] . Conversely, the same modification can entail an escape from immune surveillance [33] . In conclusion, the role of antigen nitration may be unique in respect to any given scenario.
Outline of the study
In this study we address the role of antigen nitration with respect to experimental CNS autoimmunity. We used the well-established EAE antigen, recombinant mouse Myelin Oligodendrocyte Glycoprotein (rmMOG), and examined whether nitration would affect its antigenicity. Our approach builds on a thorough biochemical analysis, translation into 3D-models of the antigen or MHC/epitope complexes and culminated in the in vivo validation thereof. Our results explain at the molecular level the observation that nitrated MOG is poorly encephalitogenic in H2 b C57BL/6 mice. However, we also establish that this is an MHC-dependent effect as H2 q DBA1 mice remain fully susceptible to EAE induced by nitrated MOG. The implications of protein nitration in EAE and human MS and its therapy are discussed in the context of recent studies.
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Materials and Methods
Recombinant mouse MOG production and nitration
Recombinant mouse MOG (rmMOG, residues 1-121+LEHHHHHH HIS tag) was expressed in E. coli and purified using an automated multistep procedure (ÄKTA, GE Healthcare) involving purification by Immobilized Metal Affinity Chromatography (IMAC), endotoxin removal, on-column refolding, followed by elution and re-looping to an Ion Exchange Chromatography Column (IEXC) to exchange the buffer and elute the monomeric and soluble MOG fraction.
rmMOG aliquots (~1.5 mg/mL) were nitrated by incubation at RT with peroxynitrite (~10mM final, Millipore) for >10 min (mild shaking), followed by extensive dialysis to PBS, pH 7.4 (3500 MWCO filter, >4 complete buffer exchanges against excess volume over a total time of min. 24h). Negative controls using degraded peroxynitrite were included and control protein was dialyzed in parallel.
Biochemical analyses SDS-PAGE was performed using 4-20% gels (BioRad) and ~1 µg of pure protein input.
Proteins were visualized in-gel using a Coomassie Brilliant Blue R250 staining protocol. For Western Blotting, proteins were transferred to nitrocellulose membranes (BioRad reagents) and blots were probed using the Li-COR Odyssey® system and associated reagents for infrared secondary antibodies. Primary antibodies: 8-18C5 anti MOG (mouse monoclonal, in-house production), anti-HIS-tag (mouse monoclonal, Serotec MCA1396), anti-3-nitrotyrosine (rabbit polyclonal, Sigma, N0409) applied 1:1000.
Isoelectric focusing (IEF) was performed using Novex® systems and reagents and ~5 µg of protein input.
In-solution digestion
Protein samples were diluted in 50 mM NH 4 HCO 3 buffer, reduced with dithiothreitol (DTT ~10 mM final) for 15 min at 56°C and then alkylated by addition of Iodacetamide (IAA, ~20 mM final) for 15 min in darkness. In-solution digests were prepared using either Trypsin or Glu-C (5% w/w). The digestion was performed at 37°C overnight. . The peptide mixture was vacuum centrifuged to dryness using a Speedvac system ISS110 (Thermo Scientific, Waltham, MA, USA) and reconstituted in 10 μL of 0.1% trifluoroacetic acid prior to nanoLC-MS/MS analysis.
NanoLC-MS/MS
On-line nano liquid chromatography (nLC) was performed using an EASY-nLC II system (Thermo Fischer Scientific). The peptide separations were performed on in-house packed 15-cm fused silica emitters (75-µm inner diameter, 375-µm outer diameter). The emitters were packed with a methanol slurry of reversed-phase, fully end-capped Reprosil-Pur C 18 -AQ 3 µm resin (Dr. Maisch GmbH, Ammerbuch-Entringen, Germany) using a PC77 pressure injection cell (Next Advance, Averill Park, NY, USA).At a flow rate of 200 nL/min a gradient between Solution A (0.1% formic acid) and solution B (99.9% ACN and 0.1% formic acid) was generated as follows: 2%B-35%B over 17 min, 35-50%B for 5 min, 80% B M A N U S C R I P T
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6 for 16 min (wash). The online nanoLC was connected to an LTQ Orbitrap mass spectrometer equipped with a nano flex ion source (Proxeon Biosystems).
The LTQ Orbitrap Velos Pro instrument was operated using Tune 2.6.0 and Xcalibur 2.1 and was set to automatically alternate between surveying the mass spectrum in the Fourier transform mass spectrometer (FTMS) at 60000 FWHM and performing the collision induced dissociation (CID) fragmentation of the 10 most abundant ions in the ion trap. Full scan CID MS spectra (m/z 400-2000) were acquired in the Orbitrap analyzer. MS2 of fragment ions was performed in the low pressure ion trap using a 35% normalized collision energy, an activation time of 10 ms and q=0.25 at normal scan rate and recorded using the secondary multipliers.
Mass Spec Data Analysis
Data analysis was performed using Proteome Discoverer v. 1.4 and SEQUEST (Thermo Fischer Scientific). The introduced carbamidomethylation (+57.021 Da, static) and potential dynamic artifacts such as deamidation (+0.984 Da) or oxidation (+15.995 Da) were accounted for while searching for tyrosine or tryptophan nitrations (+44.985 Da) using unimod (www.unimod.org/) entries. We obtained sequence coverage of 100% for native rmMOG and ~92% for the nitrated samples. The occurrence of nitration was evaluated at the peptide level using high-confidence hits with matching retention times. Notably, the retention time for nitrated peptides tended to be slightly longer than for native ones, which is a known effect [34] . For matching peptides we were able to detect peptides pairs without and with nitration in the respective samples (Suppl. Fig. 1 ).
In order to crudely quantify the degree of peptide nitration, which is not entirely possible due to the nature of mass spectrometry sampling and detection, we performed additional analysis in R [35] (https://www.R-project.org/) making use of the Total Ion Count (TIC) and the fact that protein inputs were pure. The TIC was used to calculate the frequency (% of TIC) over retention time. The abundance (= integrated frequency) was estimated by integration of the frequency with a small margin (±2.5 s) at the peptide's given retention time. Within matching peptides groups this integrated frequency was used to estimate the relative abundance (ratio to the sum of native control peptides). In cases where both native and nitrated peptides were detected for nitrated rmMOG samples, we also estimated the relative frequency (% of sum).
Molecular model of nitrated MOG and surface accessibility
The existing crystal structure of mouse MOG [PDB: 1PY9] [36] was used to calculate the solvent-accessible surface area for each atom in the PyMOL Molecular Graphics System (Schrödinger, LLC., http://www.pymol.org/). The maximum accessible area for position 3 of tyrosine residues (CE1 or CE2) or any potential tryptophan carbon (CE3, CH2, CZ2, CZ3) was used as a surrogate measure for the probability of nitration. Nitrations were introduced into the model using PyTMs version 1.2 [3] and a surface cutoff of 5Å 2 . For the graphical representation the model is displayed as a B-factor ribbon allowing assessment of the flexibility of protein stretches inside a transparent surface outline of the original model before nitration. Residues of interested were highlighted as stick-ball models.
Molecular model of the H2-IA b / MOG 35-55 complex
Starting from the crystal structure of H2-IA b with a human CLIP peptide [PDB: 1MUJ] the clip peptide was gradually replaced with the corresponding residues of MOG 35-55, thereby building the complex inside-out in a guided fashion. The resulting crude model of the complex was subjected to several rounds of sterical strain optimization using WinCoot [37] . Notably, this approach ignores charge effects but accounts for sterical overlap. The nitrated version was similarly generated using PyTMs [3] and correspondingly subjected to sterical optimization. The obtained molecular models correspond well to functional data [38] and previous dockings using another H2-IA b structure [PDB: 1LNU] [39] .
H2-IA b epitope motif and peptide affinities
We generated a position specific frequency matrix from aggregate scores originally generated by Zhu et al. [40] . From this matrix we generated a motif stack using R [35] in order to visualize the bits for the individual positions of H2-IA b . The resulting stack was further compared to the MOG 40-48 core epitope.
Using the online tool for MHC class II epitope prediction (http://tools.iedb.org/mhcii/) [41] and the available mouse H2-IA b we evaluated predicted affinities for peptides of MOG in which Y 40 was substituted by all available amino acids. For the resulting core sequences (p1-p9) we analyzed the best-case scenario, i.e. minimum IC 50 and percentile rank.
Animals
Animal experimentation conformed to Swedish legislation and was approved by the local ethical committee with permits N162/12 and N138/14. Mice (C57BL/6J or DBA1/J, aged ~8-12 weeks) were purchased from Jackson and housed locally in the facilities of the Department of Comparative Medicine (AKM Solna, L8) and allowed to acclimatize >1 week prior to any experiments. T cell transgenic 2D2 mice were bred locally. Housing conditions were as follows: ~5 mice per makrolon type 3 cage, wood chips bedding, cardboard housing and nesting material, stable temperature, 12h day/night cycle, free access to chow and water and dental-care wood piece. EAE animals additionally received access to soaked food, extended water nipples and soft nesting material. Animals were specific pathogen-free and monitored under FELASA regulations.
Antigen stimulations using Thymidine incorporation assays (2D2 and ex vivo)
Spleens (naive 2D2) or inguinal lymph nodes (immunized C57BL/6 at day 7-10) were obtained from sacrificed animals. Cells were recovered by mashing tissues in medium through 40 µm cell strainers (Falcon) and centrifuging (300 x g, 10 min). In case of spleens, erythrocytes were removed using ACK lysing buffer (GIBCO) and ensuing washes according to the manufacturer's protocol. After washing and resuspension cells were counted using a cell Scepter™ (Millipore). Splenocytes/lymphocytes were cultured in Dulbecco's modified Eagles Medium (DMEM, Sigma) supplemented with 10% heat-inactivated fetal bovine serum (FBS, Sigma), 100 U/mL penicillin, 100 µg/mL streptomycin, 2 mM L-glutamine, 1 mM Sodium pyruvate and 20 µM β-Mercaptoethanol (all reagents from Life Technologies) at 2.5x10 5 cells/well in 96-well round bottom plates (Sarstedt) plating 100 µL and adding 100 µL of media with stimulations. The final antigen concentrations were 50 µg/mL for proteins or 1-100 µg/mL (as indicated) for peptides (Anaspec/BioNordika), media alone serving as baseline control. Incubation conditions were standard (37°C, 5% CO 2 ). Thymidine incorporation assays were performed to assess proliferation: after ~48 h of culture 1 µCi/well of H 3 -methyl-thymidine (Perkin Elmer) was added and cells allowed to proliferate for additional 16h. Finally the cells were harvested and processed to allow measuring the counts per minute (CPM) using MeltiLex™ sheets and a scintillation beta counter (Wallac/ Perkin Elmer) according to the manufacturer's instructions. The stimulation index (SI) was calculated relative to rmMOG controls. 
Experimental autoimmune encephalomyelitis (EAE)
Nitrated MOG is negatively charged
We nitrated rmMOG using peroxynitrite and performed a biochemical characterization. Nitrated rmMOG partially migrated differently on SDS-PAGE, yielding a separation of the ~15kDa band (Fig. 1A) . The shift is too large to be a result of additional size due to nitrations. Instead the additional band may represent charge-dependent alterations in the migration behavior and/or partial denaturation due to reduced binding of SDS. Notably, nitration of rmMOG negates its recognition by the classical anti-MOG monoclonal antibody 8-18C5, suggesting that the binding mode and/or antibody epitopes may be affected by nitration (Fig. 1B) . Conversely, the recognition using the C-terminal HIS-tag was not impaired (Fig. 1B) . Detection by HIS-tag staining also reveals covalent multimers of rmMOG in the form of dimers (~30kDa) and trimers (~45kDa). Formation of such multimers is a known by-product of peroxynitrite-induced nitration attributed to the formation of dityrosines [42] . Correspondingly, all bands for nitrated rmMOG were detected using anti-3-nitrotyrosine antibodies (Fig. 1B) , but the intensity decreased with size. Finally, we performed isoelectric focusing which revealed a drastic drop in the isoelectric point (pI) for nitrated rmMOG, demonstrating an increased net negative charge (Fig. 1C) . This is consistent with the lowering of the pKa value for nitrotyrosine from 10.1 to ~7.2-6.7 [6, 8, 43] . Taken together we established that rmMOG is nitrated by peroxynitrite and becomes more negatively charged. (Fig. 1D) . Additionally, Y 121 and W 121 , though absent in the three-dimensional molecular model, were inferred as being accessible as part of the flexible C-terminus.
MOG is mainly nitrated the four surface-accessible tyrosines
The molecular prediction was confirmed by the experimental validation using ESI-MS/MS (Fig. 1E and Suppl. Fig. 1 ). We detected nitration of all the residues predicted as being accessible, namely Y 10 , Y 40 , Y 105 and Y 120 . Notably, under these experimental conditions the solvent-exposed tryptophan residue Y 121 was not detected to be nitrated. However, it should be noted that this may require alternative reaction conditions in order to be achieved [44] . Importantly, nitration was generally not observed for inaccessible residues predicted to be shielded. However, although we mostly detected peptides that did not contain nitrations for the inaccessible Y 65 residue, we did detect few peptides that were nitrated (Fig. 1E and Suppl. Fig. 1) . Notably, residue Y 65 is localized within a flexible loop region (Fig. 1F ) that in some cases may adopt an accessible conformation, which also explains the presence of additional non-dimeric bands on SDS-PAGE (Fig. 1A) . Importantly, no nitration was observed for the remaining buried and less flexible residues W 39 , Y 51 or Y 96 .
In Fig. 1F we selectively introduced surface-accessible nitrations into the molecular model of rmMOG (PDB: 1PY9) using the PyMOL PyTMs plugin [3] . Together with the transparent surface representation one can appreciate location of the buried and non-modified residues, as opposed to the accessible modified ones. Additionally, the peptide backbone and flexibility is represented as a B-factor ribbon, highlighting the flexible region harboring the poorly nitrated Y 65 . complex was also subjected to sterical optimization, an approach that accounts for sterical adaptations of the complex but ignores charge effects. In this setting, the H2-IA b complex could potentially adapt to sterically fit the larger nitrotyrosine residue in MOG by expanding the p1 pocket (Fig. 3A) . This is not surprising as the epitope consensus motif for H2-IA b reveals that the p1 pocket is capable of accommodating other aliphatic amino acids, including phenylalanine, valine and tryptophan (Fig. 2C) . Furthermore, we used a bioinformatics approach to predict epitope affinities of MOG -derived peptides to H2-IA b [41] . Indeed, binding affinity analysis of MOG in which position 40 was substituted to all known classical amino acid residues revealed that the native tyrosine variant has the highest affinity to H2-IA b , followed by phenylalanine (Fig. 3D ). While substitution with tryptophan lowered affinity by 3.3-fold, all remaining residues were very low affinity and predicted to diminish binding for the MOG epitope. Similarly, substitution of Y 40 to nitrotyrosine with a wider side chain resembles the side chain of a tryptophan and should significantly reduce the binding affinity of a PTM APL peptide variant. Furthermore, the p1 pocket of H2-IA b is mainly lined by hydrophobic residues (Fig. 3B ) and features the glutamic acid residue E 86 at its base. This setup is mirrored in the consensus motif ( Fig 2C) mostly containing amino acid residues with aliphatic regions, but being dominated by a tyrosine that can bind efficiently through hydrophobic interactions and further be stabilized via interactions with the electronegative E 86 at the bottom of the pocket. In conclusion, the p1 pocket of H2-IA b is optimal for complexing tyrosine and phenylalanine residues, while remaining deviating alternatives reduce the affinity to H2-IA b .
Although the nitrated p40NIY residue is predicted to sterically fit within the p1 pocket with minor displacement of the side chains of the H2-IA b residues W 43 and A 52 ( Fig. 3B) , it should be noted that the molecular model of H2-IA b in complex with the nitrotyrosinated APL ignores charge effects. Importantly, the nitro group (NO 2 ) is considered as polar due to the fact that the oxygen atoms feature a partial negative and the nitrogen atom a partial positive dipole. Furthermore, the pKa value of nitrotyrosine is 7.2-6.7 as opposed to 10.1 for tyrosine [6, 8, 43] . This makes nitrotyrosine much more likely to be deprotonated. In other words, at pH 7.4 more than 50% of nitrotyrosine residues are expected to be negatively charged, which is consistent with our isoelectric focusing results (Fig. 1C) . Thus although the mere size of the nitrotyrosine residue could be accommodated within the p1 pocket of H2-IA b , its charge will not allow it (Fig. 3) . This is further supported by the fact that MOG peptides with negatively charged residues at position 40 have the lowest predicted affinities (Fig. 3D ).
In conclusion, the constraints due to wider size and electronegativity of the nitrotyrosine side chain render this residue unsuitable for accommodation in the p1 pocket, and would most probably significantly reduce and/or abrogate binding of the APL to H2-IA b .
MOG 35-55 -reactive T cells do not proliferate towards nitrated MOG
Our structural biochemistry results warranted a functional evaluation of the hypothesis that nitrated MOG or the MOG 35-55p40NIY APL would not be presented and hence not be encephalitogenic in the EAE model. First we tested both native and nitrated MOG protein, as well as the MOG and MOG peptides in an ex vivo proliferation assay using splenocytes from TCR transgenic 2D2 mice. 2D2 T cells express a transgenic TCR specific to H2-IA b /MOG , thus enabling the assessment of presentation and recognition of this particular antigen by the defined TCR. As predicted, 2D2 splenocytes proliferated in response to rmMOG, but not to nitrated rmMOG (Fig. 4A) . This was further confirmed using a titration of the MOG and MOG peptides (Fig. 4B) , demonstrating that the nitrated peptide requires significantly higher doses to achieve comparable proliferation and consistently yields an inferior proliferation of 2D2 splenocytes. This strongly support the conclusions that the nitrated APL, and more specifically the nitrated NIY 40 , have lowered affinity to H2-IA b .
Finally, we performed an ex vivo re-stimulation of lymphocytes retrieved from mice with prior immunization with native or nitrated MOG proteins. These assays demonstrated that lymphocyte proliferation occurred only towards MOG from mice immunized with wild-type MOG (Fig. 4C) . Conversely, there was essentially no proliferation towards nitrated MOG, nor did lymphocytes from mice immunized with nitrated MOG proliferate towards either native or nitrated MOG (Fig. 4C) . Taken together, the polyclonal ex vivo re-stimulation assays mimic our results using 2D2 lymphocytes, implying that nitrated MOG fails to induce significant T cell responses.
Nitrated MOG or the MOG 35-55p40NIY APL are not encephalitogenic in H2 b C57BL/6 mice
From the in vitro and ex vivo experimentation we expected nitrated MOG to be poorly encephalitogenic in vivo. To address this C57BL/6 mice were immunized with the respective native or nitrated MOG proteins or peptides described above. In contrast to native rmMOG, immunization with nitrated rmMOG resulted in a lower incidence and significantly milder EAE in H2 b C57BL/6 mice (Fig. 4D ). Accordingly, we were able to induce EAE with the MOG 35-55 peptide but not with the MOG 35-55p40NIY APL (Fig. 4E) . Taken together, these data support the notion that nitration of MOG renders the dominant MOG epitope inert in the context of H2-IA b .
Nitrated MOG is fully encephalitogenic in H2 q DBA1 mice
Given the encephalitogenic inertness of nitrated MOG in C57BL/6 mice we thereafter addressed whether nitrated MOG would be generally non-encephalitogenic. To this end we immunized H2 q DBA1 mice, which are generally much more susceptible to EAE, require less adjuvant and no pertussis toxin for EAE induction [45] . Interestingly, DBA1 mice were fully susceptible to EAE induced by either native or nitrated rmMOG (Fig. 4F) . Importantly, DBA1 mice express H2 q and the dominant epitope is MOG 79-98 instead of the H2-IA brestricted MOG [45] . Notably, this epitope comprises the tyrosine residue Y 96 (Fig. 4G) . However, we have experimentally established that Y 96 is not nitrated (Fig. 1 ), most probably due to its inaccessibility. The immunodominant H2 q epitope MOG 79-98 therefore remains unaltered. This thus explains why DBA1 mice develop severe EAE, even when immunized with nitrated rmMOG. This opposing phenotype further highlights the specific MHC/peptide dependence for the initiation of autoreactivity and identifies MHC haplotype as a factor determining the ability to present post-translationally modified antigens, or epitopes thereof.
Discussion
The key finding of this study is that MOG is rendered non-encephalitogenic in H2 (Fig. 1) , and since it is the last residue of the epitope, it is unlikely to be located within the MHC groove, nor is it conserved in humans (cf. Fig 4G) . Taken together, this supports the conclusion that nitration of MOG affects presentation of epitopes in H2 b , but not H2 q mice.
Our obtained results are confined to the specific setting of the murine H2-IA b -restricted MOG 35-55p40NIY APL. Although the results are consistent with the generated models, we lack experimental evidence from binding assays for the reduced affinity of the MOG APL to H2-IA b , and we can thus not rule out perturbed interaction of the modified peptide bound in the MHC with the T cell receptor. However, the peptide titration (Fig. 4B ) strongly support our conclusions. Importantly, a previous study has demonstrated both in vitro and in vivo that substitution of Y 40 to alanine within the MOG 38-51 peptide epitope reduces both affinity to H2-IA b and T cell proliferation [46] . Furthermore, predictions of binding affinities for MOG analogs to H2-IA b agree with the aforementioned experimental data and further support the conclusion that nitrotyrosine is incompatible with the p1 pocket of H2-IA b .
Regardless, a perturbation of interaction with specific TCRs by the unlikely presented APL, possibly involving a register shift, will immunologically entail an equivalent outcome, namely the lack of a T cell response. In conclusion, the theoretical support provided by the molecular model is consistent with the deduction that the observed biological effects are attributable to a lack of presentation.
While MOG is the dominant epitope in H2 b mice, this is not the case for H2 q mice, DA rats or humans [47, 48] (Fig. 4G) . Furthermore, of all the other tyrosines, residues mouse Y 10 and Y 96 are not conserved in either rat or human MOG (Fig. 4G) . Regardless, some of the known MOG epitopes contain tyrosines that can be nitrated, while others do not (Fig 4G) . Known examples of human MOG epitope reactivity include MOG [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] and MOG 101-120 , in patients with the MS risk haplotype DRB1*1501/0602 DQB1*0301/0201 [47] . However, to our knowledge still nothing is known about any putative corresponding MHC/peptide complexes in this respect, and the molecular interactions of MS antigens and risk haplotypes remain elusive. Conversely, there are also epitope reactivities in humans that are predicted to be unaffected by nitration (Fig 4G) . There is thus a clear potential for individual MS patients to mirror the situation we face when comparing the EAE model in C57BL/6 and DBA1 mice:
We only observed a diminished encephalitogenicity of nitrated MOG in the context of the H2-IA b -restriced MOG epitope, whereas H2 q mice did not have that phenotype. Whether nitration of antigen may entail any biological effect will therefore be determined by the given MHC haplotype and existing epitope reactivities. Furthermore, molecular modeling and bioinformatics analyses indicate a reduced capacity of nitrated MOG to be presented by H2-IA b , an opposite scenario may be the case for a different antigen and MHC haplotype combination [30] . In rheumatoid arthritis for instance, there is structural evidence that citrullinated antigens are preferably presented by risk haplotypes [49] . In regard to human MS, however, the heterogeneity of the respective MHC molecules and the still largely elusive spectrum of myelin-derived MHC-restricted epitopes pose a considerable translational barrier to addressing any questions related to the presentation of modified antigens [9] . Accordingly, although it is conceivable that nitration-depended abrogation or enhancement of immunogenicity may occur in human disease, this remains to be established with concrete examples.
RNS-mediates tissue damage versus antigen nitration -implications for iNOS
How protein nitration associated with CNS inflammation or cellular stress may relate to initiation of progression of MS is currently unclear [15] . Previous studies addressing the role of iNOS in the EAE model consistently reported increased incidence and severity in mice lacking iNOS [19] [20] [21] . Other studies reported ambiguous effects with inhibition of iNOS being protective in passive EAE but promoting in active MBP-EAE [22] . Targeting RNS in active EAE was independently reported to yield beneficial effects [23, 26] .
Arguably, the roles of iNOS or RNS can be manifold in respect to their potential roles in regulating inflammatory activity, mediating tissue damage, inducing apoptosis or modifying antigens. This present study is related to the latter and we have demonstrated that nitrated MOG is non-encephalitogenic on an H2 b background due to lack of presentation (Fig. 4) .
Hence, antigen nitration is a mechanism through which T cell epitopes can be silenced, provided either anchoring residues or T cell contacts are affected, thus diminishing antigen presentation or T cell recognition, respectively [33] .
However, how realistic is it that the majority of antigen actually becomes nitrated to a degree that would warrant an effective silencing in vivo? The proportion of antigen nitration in situ by RNS is arguably only a fraction of the available proteins, and the nitration of MOG in vitro does not mimic partial nitration in vivo. Conversely, inflammatory monocytes and macrophages actively subject their phagolysosomes to oxidative burst, involving iNOS and NADPH oxidase. Hence antigens presented by inflammatory antigen presenting cells (APCs) are more likely to have undergone nitration [32] . Interestingly, various APCs differ in their iNOS activity [50] . In this context it has been demonstrated that macrophage-derived ROS negatively regulate autoimmune priming [5] . Conversely, mice lacking negative regulation of oxidative burst in phagocytes develop severe EAE, owning to extensive tissue damage [51] . The latter presents an over-layering effect highlighting the duality of RNS-mediated effects: immediate damage mediated by RNS and mitochondria [26] has to be distinguished from downstream effects that adducts related to ROS/RNS stress may have on carrier antigen. In this particular context our data imply that the outcome of antigen nitration depends on MHC haplotype.
Altogether, these notions need to be elucidated in further detail. With respect to the degree of nitration in situ it is important to dissect the source and final location of RNS. There may be over-layering effects depending on whether the cells are activated or stressed, whether RNS production occurs in lysosomes or mitochondria, and whether the production is internallycontained or tissue-directed [7, 8, 14, 24, 26, 29, 52] . Furthermore, the antigen itself, the type of APC, cellular activation state and MHC haplotype are all expected to influence the fate of phagocytosed antigen significantly.
A role for nitration affecting epitope recognition and immune responses
While the literature offers evidence for antigen nitration both promoting or counteracting inflammation [30, 33] within 4.5Å (with cyan/ orange color, respectively). Note that NIY 40 is angled compared to Y 40 and that the nitro group is mainly accommodated by dislocation of TRP 43 , PHE 48 and ALA 52 of the MHC α chain. The overall orientation of the remaining residues is essentially identical. C) Simplified representation of B) depicting the gross adaptations in the models. While the p1 pocket of H2-IA b could physically adapt to accommodate the size of the nitrotyrosine, it is highly unlikely that this would occur. Importantly, the nitro group is considered polar and the nitrotyrosine is expected to be negatively charged. Conversely, the MHC cavity is clearly lined by hydrophobic residues (cf. B) and features a negatively charged GLU 86 (β chain) at its base that would normally mediate hydrogen bonding. Firstly, the polarity of the nitro group would counteract hydrophobic interactions in the pocket. Secondly, the increased negative polarity/charge of the hydroxyl group would be repelled by the negatively charged GLU 86 . Taken together, it is highly unlikely that MOG can effectively be presented by H2-IA b .
D) Peptide binding affinities for peptides based on MOG , but substituted at position 40 with other standard amino acids were predicted using an online bioinformatics approach [41] . For every core motif (p1-p9) we obtained the minimum IC 50 and percentile rank values, i.e. the best-case scenario. Fold change was calculated as ratio to the original tyrosine. The replaced residue is bold and underlined. Asterisks indicate core motifs that involve register shifts.
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